scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.CANLET.2004.05.023 |
P698 | PubMed publication ID | 15488643 |
P2093 | author name string | Jie Zheng | |
Ling Chen | |||
Hong-mei Li | |||
Jiang-feng You | |||
Wei-gang Fang | |||
Wan-jie Heng | |||
Hui-ying He | |||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | prostate cancer | Q181257 |
tumor invasion | Q60750433 | ||
P304 | page(s) | 239-247 | |
P577 | publication date | 2004-11-01 | |
P1433 | published in | Cancer Letters | Q326372 |
P1476 | title | ERK1/2 and p38 pathways are required for P2Y receptor-mediated prostate cancer invasion. | |
P478 | volume | 215 |
Q33873659 | ATP-P2Y2-β-catenin axis promotes cell invasion in breast cancer cells |
Q90055497 | Antiproliferative and Anti-invasion Effects of Carvacrol on PC3 Human Prostate Cancer Cells through Reducing pSTAT3, pAKT, and pERK1/2 Signaling Proteins |
Q38567609 | CXCR4 chemokine receptor mediates prostate tumor cell adhesion through alpha5 and beta3 integrins |
Q37198990 | Extracellular ATP and cancer: an overview with special reference to P2 purinergic receptors. |
Q98158767 | Extracellular ATP promotes breast cancer invasion and chemoresistance via SOX9 signaling |
Q39538019 | Gadolinium inhibits prostate cancer PC3 cell migration and suppresses osteoclast differentiationin vitro |
Q26991904 | Important roles of P2Y receptors in the inflammation and cancer of digestive system |
Q35540734 | Inhibition of p38-MAPK signaling pathway attenuates breast cancer induced bone pain and disease progression in a murine model of cancer-induced bone pain. |
Q60936264 | Involvement of the glutamine RF‑amide peptide and its cognate receptor GPR103 in prostate cancer |
Q33369573 | MAP kinase pathways and calcitonin influence CD44 alternate isoform expression in prostate cancer cells |
Q54999827 | MiR-1271 Inhibits Cell Growth in Prostate Cancer by Targeting ERG. |
Q36174261 | Nucleotide receptor signalling and the generation of reactive oxygen species |
Q37677827 | Nucleotides and nucleoside signaling in the regulation of the epithelium to mesenchymal transition (EMT). |
Q41895729 | P2 receptors in renal pathophysiology |
Q35500124 | P2X7 mediates ATP-driven invasiveness in prostate cancer cells |
Q35693663 | P2Y2 Receptor and EGFR Cooperate to Promote Prostate Cancer Cell Invasion via ERK1/2 Pathway |
Q37182251 | P2Y2 receptor promotes cell invasion and metastasis in prostate cancer cells |
Q47634604 | P2Y2 receptor promotes the migration and invasion of breast cancer cells via EMT-related genes Snail and E-cadherin |
Q52936872 | Proteomics analysis of malignant and benign prostate tissue by 2D DIGE/MS reveals new insights into proteins involved in prostate cancer. |
Q24618782 | Purinergic signalling and cancer |
Q38061933 | Purinergic signalling in the lower urinary tract |
Q26820842 | Purinergic signalling in the reproductive system in health and disease |
Q37392558 | Role of p38 MAP Kinase Signal Transduction in Solid Tumors |
Q39847370 | Suppression of ErbB-2 in androgen-independent human prostate cancer cells enhances cytotoxic effect by gemcitabine in an androgen-reduced environment |
Q53244075 | The activation of P2Y2 receptors increases MCF-7 breast cancer cells migration through the MEK-ERK1/2 signalling pathway. |
Q92770702 | The protective role of the MKP-5-JNK/P38 pathway in glucolipotoxicity-induced islet β-cell dysfunction and apoptosis |
Q97435733 | Using Cytometry for Investigation of Purinergic Signaling in Tumor-Associated Macrophages |
Q48144894 | p38 differentially regulates ERK, p21, and mitogenic signalling in two pancreatic carcinoma cell lines |
Search more.